Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease

Apr 4

Written By Yiran Gan

2020.01.21

CW Chang, SY Yang, CC Yang, CW Chang and YR Wu

Front. Neurol., 21 January 2020

https://www.frontiersin.org/articles/10.3389/fneur.2019.01388/full

Composite Scores of Plasma Tau and β-Amyloids Correlate with Dementia in Down Syndrome

Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease